Amgen to invest $600 million in new R&D facility in California
Biotechnology giant Amgen Inc. has announced a major investment exceeding $600 million to construct a state-of-the-art research and development (R&D) center at its global headquarters in Thousand Oaks, California. This move underscores the company’s commitment to advancing scientific innovation amid a shifting U.S. pharmaceutical landscape, where domestic investments are surging in response to potential trade … Read more